MMP2 and triple-A syndrome: In the present study, we demonstrated that a selective EP4 antagonist CJ‐42794 decreased AAA formation in an angiotensin II‐induced model in ApoE−/− mice, in which elastic fiber degradation and activation of MMP‐2 and MMP‐9, and IL‐6 production were attenuated.